Ionian Technologies Gets Gates Funding for MDx Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Ionian Technologies today said that it has received additional funding from the Bill & Melinda Gates Foundation to continue developing a molecular diagnostics platform designed for use in the developing world.

The San Diego-based firm said that its total commitment from the Gates foundation has risen to $3 million over two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.